Leading A tRNA Startup With Alltrna's Michelle Werner
Business Of Biotech
00:00
Innovating tRNA Delivery with LNPs
This chapter explores the strategic use of lipid nanoparticles (LNPs) for delivering tRNA therapeutic agents, building on their proven safety from COVID mRNA vaccines. The speakers discuss scaling manufacturing processes and regulatory complexities, particularly with the FDA, as they prepare for early-stage clinical trials. Emphasizing historical lessons and partnerships, the chapter outlines a promising path for tRNA technology to tackle various rare diseases.
Transcript
Play full episode
